Diffuse intramedullary spinal lesions present formidable diagnostic dilemmas for neurosurgeons and neurologists alike. When advanced neuroimaging and systemic investigations fail to deliver an etiological answer, a primary spinal cord biopsy becomes a critical diagnostic step. However, navigating the parenchymal architecture of the spinal cord introduces profound neurological risks. Clinicians must balance securing informative tissue against inducing functional motor or sensory impairment. Recent multicenter European evidence illuminates the safety profiles, diagnostic efficacy, and surgical techniques required to optimize patient outcomes.

Indications and Challenges of Spinal Cord Biopsy

Diagnostic uncertainty frequently complicates the management of non-compressive, diffuse spinal cord abnormalities. In clinical practice, inflammatory myelopathies, demyelinating conditions, vascular anomalies, and primary neoplasms often present with remarkably similar radiological features. Consequently, empirical therapies such as high-dose corticosteroids can alter histological features without conferring lasting clinical benefit. When exhaustive systemic evaluations and cerebrospinal fluid analyses remain inconclusive, clinicians must consider an invasive parenchymal biopsy. Nevertheless, entering the delicate spinal cord architecture raises understandable trepidation. Because the spinal cord lacks anatomical redundancy, even minor tissue manipulation can trigger devastating deficits. Moreover, the fear of non-diagnostic tissue constantly challenges neurosurgical teams. If the biopsy instruments harvest purely reactive or necrotic margins, patients endure procedural trauma without therapeutic clarity. Therefore, clinicians require robust clinical parameters to determine which individuals genuinely benefit from operative sampling. Preoperative planning must carefully assess lesion boundaries, enhancement dynamics, and the patient's baseline neurological reserve. Ultimately, neurosurgeons should reserve invasive parenchymal biopsy for cases where tissue confirmation decisively alters clinical management.

Diagnostic Yield and Anatomical Predictors of Success

Recent multicenter European data spanning eight tertiary neurosurgical centers provide valuable insights into procedural efficacy. Among sixty-one consecutive patients undergoing primary biopsy, neuropathologists secured an informative histological diagnosis in 91.8% of cases. Thus, modern microsurgical biopsy yields reliable diagnostic results when performed in specialized centers. However, the investigation identified an anatomical factor that significantly hampers diagnostic success. Specifically, lesions extending across more than three spinal levels correlated significantly with inconclusive, non-diagnostic biopsies. This counterintuitive finding suggests that longitudinally extensive lesions often consist of prominent perilesional edema or diffuse gliosis rather than concentrated neoplastic cells. Consequently, blind or unguided tissue harvesting in multi-segment lesions frequently captures non-specific reactive parenchyma instead of diagnostic pathology. Furthermore, extensive cord swelling can distort native landmarks, making precise spatial targeting difficult. Therefore, neurosurgeons must meticulously evaluate preoperative magnetic resonance imaging to identify focal nodules displaying marked contrast enhancement or restricted diffusion. By directing sampling toward discrete metabolic targets rather than expansive edematous regions, surgical teams maximize diagnostic yield while preserving surrounding neural tissue.

Perioperative Neurological Deterioration and Tumor Subtypes

Although the diagnostic yield remains high, perioperative morbidity represents a major clinical concern in intramedullary interventions. In the multicenter cohort, 47.5% of patients experienced immediate postoperative neurological deterioration. Fortunately, 48.3% of these patients recovered to their preoperative baseline within three weeks, reflecting the temporary nature of edema-induced conduction block. Nevertheless, persistent deficits occurred in a meaningful subset of individuals. Multivariable analysis identified low-grade glioma and intramedullary lymphoma as independent risk factors for postoperative deterioration. This vulnerability reflects distinct pathophysiological mechanisms inherent to these tumor entities. Low-grade astrocytomas infiltrate intimately among functional axonal pathways without clear demarcation planes, making parenchymal sampling hazardous. Conversely, spinal lymphomas provoke severe microvascular compromise and intense peritumoral inflammatory edema. When surgeons incise cord tissue affected by lymphoma, the fragile parenchyma reacts with acute conduction failure and swelling. Consequently, surgical teams must exercise heightened caution when preoperative investigations suggest these pathologies. Furthermore, detailed preoperative counseling is indispensable to ensure patients understand the substantial risk of functional decline before consenting to surgery.

Intraoperative Ultrasound as an Essential Safeguard

To mitigate procedural risks, neurosurgeons increasingly incorporate real-time imaging adjuncts into their operative workflow. Crucially, the multicenter study demonstrated that intraoperative ultrasound was significantly associated with reduced postoperative neurological deficits. Unlike cranial biopsy where stereotactic navigation provides dependable coordinates, the spinal cord shifts unpredictably after durotomy and cerebrospinal fluid release. Intraoperative ultrasound addresses this limitation by delivering real-time, high-resolution acoustic imaging through the intact dura or direct myelotomy site. Consequently, surgeons can accurately delineate the pathological core from viable spinal tracts before incising the parenchyma. Furthermore, ultrasound differentiation assists in identifying necrotic zones, cysts, and hypervascular areas that should be avoided during tissue acquisition. By selecting an optimal entry corridor through the dorsal median sulcus, the neurosurgeon protects descending motor tracts from inadvertent mechanical trauma. Additionally, high-frequency linear transducers permit real-time confirmation of adequate lesion sampling, preventing excessive cord exploration. Therefore, intraoperative ultrasound represents an indispensable technological adjunct that directly enhances surgical precision and safeguards functional neurological outcomes.

Preoperative Discrepancies and Multidisciplinary Framework

The clinical necessity of surgical verification becomes apparent when assessing diagnostic accuracy prior to intervention. Remarkably, the multicenter analysis demonstrated that preoperative clinical and radiological diagnoses differed from final histopathology in 47.5% of cases. This finding highlights the profound fallibility of relying solely on neuroimaging to guide long-term therapies. For example, tumefactive demyelinating lesions frequently mimic malignant astrocytomas, whereas primary central nervous system lymphomas can masquerade as idiopathic transverse myelitis. Initiating aggressive oncological resection or radiotherapy for an inflammatory disease causes severe iatrogenic harm. Conversely, managing unrecognized high-grade malignancy or fungal infection with immunosuppressive steroids produces temporary radiological improvement followed by rapid clinical deterioration. Therefore, invasive biopsy provides an essential diagnostic anchor when non-invasive workups fail. Given these complexities, biopsy decisions require thorough review within a multidisciplinary neuro-oncology tumor board. Integrating neurosurgeons, neurologists, neuroradiologists, and neuropathologists ensures balanced risk-benefit assessments. Ultimately, this collaborative governance model optimizes patient selection, avoids unnecessary surgical exploration, and directs patients toward accurate, evidence-based treatments.

What is the overall diagnostic yield of a spinal cord biopsy?

Recent multicenter evidence confirms that spinal cord biopsies achieve a diagnostic yield of approximately 91.8%. However, diagnostic success drops significantly when diffuse lesions involve more than three spinal segments. Consequently, multidisciplinary teams must carefully evaluate lesion extent and target contrast-enhancing regions to ensure tissue adequacy while avoiding uninformative interventions.

Why does intraoperative ultrasound reduce postoperative neurological deficits?

Intraoperative ultrasound provides real-time, high-resolution visualization of the spinal cord architecture and underlying pathology. Therefore, surgeons can accurately pinpoint lesion margins and precisely plan the myelotomy trajectory. This real-time guidance avoids unnecessary manipulation of delicate parenchymal pathways, significantly reducing postoperative deficits and preserving essential functional tracts.

Which clinical pathologies carry the highest risk of post-biopsy deterioration?

Low-grade gliomas and spinal lymphomas represent independent risk factors for postoperative neurological deterioration. Because low-grade gliomas blend diffusely into functional pathways and lymphomas provoke intense parenchymal inflammation, surgical disruption frequently triggers deficits. Consequently, clinicians should exhaust non-invasive diagnostic evaluations, including systemic imaging and cerebrospinal fluid examinations, before undertaking invasive sampling.

Disclaimer: This content is for informational and educational purposes only. It does not constitute formal medical advice, diagnosis, or treatment recommendations. Clinical decisions should always be made by qualified healthcare professionals based on individual patient assessments and established medical standards. Refer to the latest local and national guidelines for clinical practice.

References

Mallereau CH et al. Tips and tricks of spinal cord biopsy: insights from a multicenter series of 61 patients. J Neurooncol. 2025 Jul. doi: 10.1007/s11060-025-05009-w. PMID: 40366520.

Regelsberger J, Fritzsche E, Langer N, Westphal M. Intraoperative sonography of intra- and extramedullary tumors. Ultrasound Med Biol. 2005;31(5):593-598. doi: 10.1016/j.ultrasmedbio.2005.01.014.

Konovalov NA, Onoprienko RA, Kaprovoy SV, et al. Surgical treatment of intramedullary spinal cord tumors: a systematic review. Burdenko's Journal of Neurosurgery. 2025;89(1):103-112.